Estimating health care costs at scale in low- and middle-income countries: Mathematical notations and frameworks for the application of cost functions.

Appropriate costing and economic modeling are major factors for the successful scale-up of health interventions. Various cost functions are currently being used to estimate costs of health interventions at scale in low- and middle-income countries (LMICs) potentially resulting in disparate cost projections. The aim of this study is to gain understanding of current methods used and provide guidance to inform the use of cost functions that is fit for purpose. We reviewed seven databases covering the economic and global health literature to identify studies reporting a quantitative analysis of costs informing the projected scale-up of a health intervention in LMICs between 2003 and 2019. Of the 8725 articles identified, 40 met the inclusion criteria. We classified studies according to the type of cost functions applied-accounting or econometric-and described the intended use of cost projections. Based on these findings, we developed new mathematical notations and cost function frameworks for the analysis of healthcare costs at scale in LMICs setting. These notations estimate variable returns to scale in cost projection methods, which is currently ignored in most studies. The frameworks help to balance simplicity versus accuracy and increase the overall transparency in reporting of methods.

[1]  Gabriela B. Gomez,et al.  Estimating Cost Functions for Resource Allocation Using Transmission Models: A Case Study of Tuberculosis Case Finding in South Africa. , 2020, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[2]  W. Zhang,et al.  Comparison of statistical and machine learning models for healthcare cost data: a simulation study motivated by Oncology Care Model (OCM) data , 2020, BMC Health Services Research.

[3]  P. Dewan,et al.  What would it cost to scale-up private sector engagement efforts for tuberculosis care? Evidence from three pilot programs in India , 2019, PloS one.

[4]  Wenxin Jiang,et al.  Simple Quasi-Bayes Approach for Modeling Mean Medical Costs , 2019, The international journal of biostatistics.

[5]  Matthew Franklin,et al.  An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis , 2019, PharmacoEconomics.

[6]  S. Prinja,et al.  Cost analysis of implementing mHealth intervention for maternal, newborn & child health care through community health workers: assessment of ReMIND program in Uttar Pradesh, India , 2018, BMC Pregnancy and Childbirth.

[7]  F. Masiye,et al.  Influence of supply-side factors on voluntary medical male circumcision costs in Kenya, Rwanda, South Africa, and Zambia , 2018, PloS one.

[8]  P. Berman,et al.  Can Ethiopia Finance the Continued Development of Its Primary Health Care System If External Resources Decline? , 2018, Health systems and reform.

[9]  M. A. Colchero,et al.  Explaining the heterogeneity in average costs per HIV/AIDS patient in Nigeria: The role of supply-side and service delivery characteristics , 2018, PloS one.

[10]  Vítor Castro.  Pure, White and Deadly… Expensive: A Bitter Sweetness in Health Care Expenditure , 2017, Health economics.

[11]  S. Bautista-Arredondo,et al.  HIV prevention costs and their predictors: evidence from the ORPHEA Project in Kenya , 2017, Health policy and planning.

[12]  B. Cissé,et al.  Large-scale delivery of seasonal malaria chemoprevention to children under 10 in Senegal: an economic analysis , 2017, Health policy and planning.

[13]  P. Winskill,et al.  Modelling the cost-effectiveness of introducing the RTS,S malaria vaccine relative to scaling up other malaria interventions in sub-Saharan Africa , 2017, BMJ Global Health.

[14]  N. Welton,et al.  Choice of statistical model for cost-effectiveness analysis and covariate adjustment: empirical application of prominent models and assessment of their results , 2016, The European Journal of Health Economics.

[15]  Nandita Mitra,et al.  Propensity score and doubly robust methods for estimating the effect of treatment on censored cost , 2016, Statistics in medicine.

[16]  Daowen Zhang,et al.  A flexible model for correlated medical costs, with application to medical expenditure panel survey data , 2016, Statistics in medicine.

[17]  A. Vassall,et al.  Foreword: Health Economic Evaluations in Low‐ and Middle‐income Countries: Methodological Issues and Challenges for Priority Setting , 2016, Health economics.

[18]  S. Moses,et al.  What Determines HIV Prevention Costs at Scale? Evidence from the Avahan Programme in India , 2016, Health economics.

[19]  A. Vassall,et al.  Does integration of HIV and SRH services achieve economies of scale and scope in practice? A cost function analysis of the Integra Initiative , 2015, Sexually Transmitted Infections.

[20]  J. Puig-Junoy,et al.  Predictors of primary health care pharmaceutical expenditure by districts in Uganda and implications for budget setting and allocation , 2015, BMC Health Services Research.

[21]  Sally Redman,et al.  Narrative review of models and success factors for scaling up public health interventions , 2015, Implementation Science.

[22]  Amal Saki Malehi,et al.  Statistical models for the analysis of skewed healthcare cost data: a simulation study , 2015, Health Economics Review.

[23]  B. Gessner,et al.  Determinants of routine immunization costing in Benin and Ghana in 2011. , 2015, Vaccine.

[24]  A. Lépine,et al.  Estimating unbiased economies of scale of HIV prevention projects: a case study of Avahan. , 2015, Social science & medicine.

[25]  E. Njeuhmeli,et al.  Cost Drivers for Voluntary Medical Male Circumcision Using Primary Source Data from Sub-Saharan Africa , 2014, PloS one.

[26]  Daowen Zhang,et al.  A flexible model for the mean and variance functions, with application to medical cost data , 2013, Statistics in medicine.

[27]  S. Resch,et al.  Using standardized tools to improve immunization costing data for program planning: the cost of the Colombian Expanded Program on Immunization. , 2013, Vaccine.

[28]  D. Bishai,et al.  A cost function analysis of child health services in four districts in Malawi , 2013, Cost Effectiveness and Resource Allocation.

[29]  K. Hunt,et al.  Joint modeling of multiple longitudinal cost outcomes using multivariate generalized linear mixed models , 2013, Health Services and Outcomes Research Methodology.

[30]  J. Stringer,et al.  Taking ART to Scale: Determinants of the Cost and Cost-Effectiveness of Antiretroviral Therapy in 45 Clinical Sites in Zambia , 2012, PloS one.

[31]  N. Menzies,et al.  The Determinants of HIV Treatment Costs in Resource Limited Settings , 2012, PloS one.

[32]  E. Bradley,et al.  Scaling up of breastfeeding promotion programs in low- and middle-income countries: the "breastfeeding gear" model. , 2012, Advances in nutrition.

[33]  T. Ensor,et al.  Budgeting based on need: a model to determine sub-national allocation of resources for health services in Indonesia , 2012, Cost Effectiveness and Resource Allocation.

[34]  K. Hort,et al.  How much does it cost to achieve coverage targets for primary healthcare services? A costing model from Aceh, Indonesia. , 2012, The International journal of health planning and management.

[35]  M. Over,et al.  HIV Treatment as Prevention: Modelling the Cost of Antiretroviral Treatment—State of the Art and Future Directions , 2012, PLoS medicine.

[36]  M. English,et al.  A Multifaceted Intervention to Improve the Quality of Care of Children in District Hospitals in Kenya: A Cost-Effectiveness Analysis , 2012, PLoS medicine.

[37]  David H Peters,et al.  Do we have the right models for scaling up health services to achieve the Millennium Development Goals? , 2011, BMC health services research.

[38]  Willard G. Manning,et al.  Estimating treatment effects on healthcare costs under exogeneity: is there a ‘magic bullet’? , 2011, Health Services and Outcomes Research Methodology.

[39]  D. Levac,et al.  Scoping studies: advancing the methodology , 2010, Implementation science : IS.

[40]  Anthony O'Hagan,et al.  Review of Statistical Methods for Analysing Healthcare Resources and Costs , 2010, Health economics.

[41]  C. Gerdts,et al.  Maternal Mortality in Developing Countries: Challenges in Scaling-Up Priority Interventions , 2010, Women's health.

[42]  P. Vickerman,et al.  The effects of scale on the costs of targeted HIV prevention interventions among female and male sex workers, men who have sex with men and transgenders in India , 2010, Sexually Transmitted Infections.

[43]  O. Ameli,et al.  Contracting for health services: effects of utilization and quality on the costs of the Basic Package of Health Services in Afghanistan. , 2008, Bulletin of the World Health Organization.

[44]  L. Kumaranayake.  The economics of scaling up: cost estimation for HIV/AIDS interventions , 2008, AIDS.

[45]  M. Salam,et al.  Mainstreaming nutrition into maternal and child health programmes: scaling up of exclusive breastfeeding. , 2008, Maternal & child nutrition.

[46]  P. Marschall,et al.  Expanding access to primary care without additional budgets? A case study from Burkina Faso , 2008, European Journal of Health Economics.

[47]  K. Hanson,et al.  The impact of micro health insurance on Rwandan health centre costs. , 2006, Health policy and planning.

[48]  C. Christiansen,et al.  Performance of statistical models to predict mental health and substance abuse cost , 2006, BMC medical research methodology.

[49]  R. Hayes,et al.  From Trial Intervention to Scale-Up: Costs of an Adolescent Sexual Health Program in Mwanza, Tanzania , 2006, Sexually transmitted diseases.

[50]  B. Arondekar,et al.  Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity. , 2006, Health economics.

[51]  D. Bishai,et al.  The costs of scaling up vaccination in the world's poorest countries. , 2006, Health affairs.

[52]  R. Pawinski,et al.  Financial and economic costs of scaling up the provision of HAART to HIV-infected health care workers in KwaZulu-Natal. , 2006, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[53]  M Christopher Roebuck,et al.  Predictive Modeling of Total Healthcare Costs Using Pharmacy Claims Data: A Comparison of Alternative Econometric Cost Modeling Techniques , 2005, Medical care.

[54]  L. Dandona,et al.  HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency , 2005, BMC public health.

[55]  H. Arksey,et al.  Scoping studies: towards a methodological framework , 2005 .

[56]  Anirban Basu,et al.  Comparing alternative models: log vs Cox proportional hazard? , 2004, Health economics.

[57]  M. Weaver,et al.  Economies of scale and scope in Vietnamese hospitals. , 2004, Social science & medicine.

[58]  Anirban Basu,et al.  Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data , 2003, Journal of health economics.

[59]  W. Manning,et al.  The logged dependent variable, heteroscedasticity, and the retransformation problem. , 1998, Journal of health economics.

[60]  J. Mullahy.  Much Ado About Two: Reconsidering Retransformation and the Two-Part Model in Health Economics , 1998, Journal of health economics.

[61]  F. Breyer,et al.  The specification of a hospital cost function. A comment on the recent literature. , 1987, Journal of health economics.

[62]  A. Donabedian.  Evaluating the quality of medical care. 1966. , 1966, The Milbank quarterly.

[63]  B. Johns,et al.  Costs of scaling up health interventions: a systematic review. , 2005, Health policy and planning.

[64]  Elamin H Elbasha,et al.  Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scale. , 2004, Health economics.

[65]  L B Lave,et al.  Hospital cost functions. , 1984, Annual review of public health.

[66]  Aroop K. Mahanty,et al.  THEORY OF PRODUCTION , 1980 .

[67]  L. Kumaranayake,et al.  Cost Effectiveness and Resource Allocation Open Access a Cost Function for Hiv Prevention Services: Is There a 'u' – Shape? , 2022 .